VMI

VHCP Management III Portfolio holdings

AUM $504M
This Quarter Return
+364.08%
1 Year Return
+678.37%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$504M
AUM Growth
+$504M
Cap. Flow
+$208M
Cap. Flow %
41.31%
Top 10 Hldgs %
90.41%
Holding
26
New
9
Increased
2
Reduced
5
Closed
8

Top Buys

1
CNST
Constellation Pharmaceuticals, Inc.
CNST
$115M
2
RLMD icon
Relmada Therapeutics
RLMD
$30M
3
ETNB icon
89bio
ETNB
$25.2M
4
FTSV
Forty Seven, Inc. Common Stock
FTSV
$20.3M
5
ITCI
Intra-Cellular Therapies Inc.
ITCI
$19.7M

Top Sells

1
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
$15.9M
2
LJPC
La Jolla Pharmaceutical Company
LJPC
$11M
3
BCRX icon
BioCryst Pharmaceuticals
BCRX
$7.76M
4
PTGX icon
Protagonist Therapeutics
PTGX
$7M
5
AXSM icon
Axsome Therapeutics
AXSM
$6.55M

Sector Composition

1 Healthcare 97.82%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AXSM icon
1
Axsome Therapeutics
AXSM
$6.05B
$160M 31.77%
1,547,994
-63,335
-4% -$6.55M
CNST
2
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$119M 23.54%
2,516,242
+2,449,575
+3,674% +$115M
MIST icon
3
Milestone Pharmaceuticals
MIST
$156M
$33.1M 6.57%
2,066,529
– –
RLMD icon
4
Relmada Therapeutics
RLMD
$37.2M
$30M 5.95%
+767,938
New +$30M
ETNB icon
5
89bio
ETNB
$1.34B
$25.2M 5%
+958,765
New +$25.2M
TXG icon
6
10x Genomics
TXG
$1.74B
$22.9M 4.54%
300,000
– –
FTSV
7
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$20.3M 4.04%
+516,381
New +$20.3M
ITCI
8
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$19.7M 3.92%
+575,000
New +$19.7M
ISEE
9
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$14.6M 2.9%
+1,699,797
New +$14.6M
KALV icon
10
KalVista Pharmaceuticals
KALV
$678M
$11M 2.19%
619,905
-17,979
-3% -$320K
ADVM icon
11
Adverum Biotechnologies
ADVM
$64.6M
$10.9M 2.16%
+946,234
New +$10.9M
MRNS
12
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$10.8M 2.15%
5,016,164
+2,500,000
+99% +$5.4M
MRSN icon
13
Mersana Therapeutics
MRSN
$36.5M
$8.95M 1.78%
+1,561,389
New +$8.95M
MYOV
14
DELISTED
Myovant Sciences Ltd.
MYOV
$7.07M 1.4%
+455,255
New +$7.07M
NXTC icon
15
NextCure
NXTC
$13.5M
$6.74M 1.34%
+119,693
New +$6.74M
OBSV
16
DELISTED
ObsEva SA Ordinary Shares
OBSV
$3.1M 0.61%
810,264
-349,525
-30% -$1.34M
PTGX icon
17
Protagonist Therapeutics
PTGX
$3.67B
$571K 0.11%
80,929
-991,419
-92% -$7M
BLPH
18
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$134K 0.03%
383,955
-2,033,272
-84% -$710K
BCRX icon
19
BioCryst Pharmaceuticals
BCRX
$1.74B
– –
-2,708,207
Closed -$7.76M
KNSA icon
20
Kiniksa Pharmaceuticals
KNSA
$2.48B
– –
-277,137
Closed -$2.36M
KA
21
DELISTED
Kineta, Inc. Common Stock
KA
– –
-221,267
Closed -$187K
TCDA
22
DELISTED
Tricida, Inc. Common Stock
TCDA
– –
-80,348
Closed -$2.48M
RDUS
23
DELISTED
Radius Health, Inc.
RDUS
– –
-23,131
Closed -$596K
PRVL
24
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
– –
-4,408
Closed -$54K
RARX
25
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
– –
-670,350
Closed -$15.9M
1
2